Inventor · disambiguated record
Raymond G. Goodwin
Also filed as: GOODWIN RAYMOND G
40 granted patents·13 pending applications·2,653 citations·filing 1988–2010
99Inventor score
Top patents by PatentIndex Score
53 records- 0198US6572852B2Method for suppressing inflammatory responses by administering TNFRIMMUNEX CORP·Filed 2001·Granted Jun 3, 2003·83 cites·8 claims
- 0297US5763223ADNA encoding a cytokine that induces apoptosisIMMUNEX CORP·Filed 1996·Granted Jun 9, 1998·231 cites·24 claims
- 0397US5480981ACD30 ligandIMMUNEX CORP·Filed 1994·Granted Jan 2, 1996·259 cites·20 claims
- 0497US5457035ACytokine which is a ligand for OX40IMMUNEX CORP·Filed 1993·Granted Oct 10, 1995·331 cites·8 claims
- 0597US5395760ADNA encoding tumor necrosis factor-α and -β receptorsIMMUNEX CORP·Filed 1990·Granted Mar 7, 1995·259 cites·20 claims
- 0696US6355779B1Cytokine designated 4-1BB ligand antibodies and human receptor that binds theretoIMMUNEX CORP·Filed 1998·Granted Mar 12, 2002·166 cites·4 claims
- 0796US6284236B1Cytokine that induces apoptosisIMMUNEX CORP·Filed 1999·Granted Sep 4, 2001·117 cites·59 claims
- 0895US5712155ADNA encoding tumor necrosis factor-α and -β receptorsIMMUNEX CORP·Filed 1994·Granted Jan 27, 1998·90 cites·17 claims
- 0995US4965195AInterleukin-7IMMUNEX CORP·Filed 1988·Granted Oct 23, 1990·291 cites·17 claims
- 1094US6201105B1Tumor necrosis factor receptor polypeptides recombinant P75 (Type II)Filed 1999·Granted Mar 13, 2001·77 cites·4 claims
- 1193US6521228B1Antibodies directed against trailIMMUNEX CORP·Filed 2001·Granted Feb 18, 2003·24 cites·35 claims
- 1293US5674704ACytokine designated 4-IBB ligandIMMUNEX CORP·Filed 1994·Granted Oct 7, 1997·123 cites·20 claims
- 1392USRE36755EDNA encoding tumor necrosis factor-α and -β receptorsIMMUNEX CORP·Filed 1998·Granted Jun 27, 2000·94 cites·1 claims
- 1491US7736637B2Use of TRAIL polypeptides to induce apoptosisIMMUNEX CORP·Filed 2008·Granted Jun 15, 2010·8 cites·8 claims
- 1590US5573924ACD27 ligandIMMUNEX CORP·Filed 1993·Granted Nov 12, 1996·82 cites·12 claims
- 1689US7138500B1Antibodies to human 4-1BBIMMUNEX CORP·Filed 1998·Granted Nov 21, 2006·50 cites·6 claims
- 1785US7057022B2Antibodies which specifically bind to TNF-RIMMUNEX CORP·Filed 2003·Granted Jun 6, 2006·13 cites·16 claims
- 1883US7459528B2Glycoproteins which bind to TNFIMMUNEX CORP·Filed 2005·Granted Dec 2, 2008·3 cites·30 claims
- 1983US6667039B1CD30 ligandIMMUNEX CORP·Filed 2000·Granted Dec 23, 2003·5 cites·32 claims
- 2083US5677430AAntibodies directed against CD30 ligandIMMUNEX CORP·Filed 1995·Granted Oct 14, 1997·28 cites·6 claims
- 2180US5945397APurified p75 (type II) tumor necrosis factor receptor polypeptidesIMMUNEX CORP·Filed 1996·Granted Aug 31, 1999·52 cites·52 claims
- 2280US5464938AIsolated viral protein TNF antagonistsIMMUNEX CORP·Filed 1994·Granted Nov 7, 1995·54 cites·6 claims
- 2379US6143869ACD30 ligand oligomers and polypeptidesIMMUNEX CORP·Filed 1998·Granted Nov 7, 2000·21 cites·8 claims
- 2478US7972812B2DNA encoding a soluble fragment of TRAIL polypeptideIMMUNEX CORP·Filed 2010·Granted Jul 5, 2011·1 cites·7 claims
- 2575US6852486B2Viral proteins capable of binding LARIMMUNEX CORP·Filed 2002·Granted Feb 8, 2005·6 cites·10 claims
- 2672US5965122AUse of interleukin-7 to stimulate proliferation of hematopoietic cell precursorsSANOFI SA·Filed 1997·Granted Oct 12, 1999·16 cites·12 claims
- 2772US5264416AInterleukin-7 receptorsIMMUNEX CORP·Filed 1992·Granted Nov 23, 1993·22 cites·8 claims
- 2870US5705149AUse of interleukin-7 to stimulate proliferation of hematopoietic cell precursorsSTERLING WINTHROP INC·Filed 1995·Granted Jan 6, 1998·19 cites·10 claims
- 2970US5543320AAntibodies to interleuken-7 receptorsIMMUNEX CORP·Filed 1993·Granted Aug 6, 1996·22 cites·6 claims
- 3069US6156301AUse of interleukin-7 to stimulate proliferation of hematopoietic cell precursorsSANOFI SYNTHELABO·Filed 1999·Granted Dec 5, 2000·19 cites·4 claims
- 3168US7232660B2CD30 ligandIMMUNEX CORP·Filed 2003·Granted Jun 19, 2007·0 cites·13 claims
- 3268US2005158823A1Method of using a cytokine that induces apoptosisIMMUNEX CORP·Filed 2004·Application pending·0 cites
- 3366US5783665ACytokine which is a ligand for OX40IMMUNEX CORP·Filed 1995·Granted Jul 21, 1998·14 cites·3 claims
- 3466US2009264349A1CD30 LigandIMMUNEX CORP·Filed 2007·Application pending·0 cites
- 3566US2004052788A1Cytokine that induces apoptosisIMMUNEX CORP·Filed 2003·Application pending·0 cites
- 3663US5328988AInterleukin-7IMMUNEX CORP·Filed 1992·Granted Jul 12, 1994·23 cites·4 claims
- 3762US5194375ADna encoding interleukin-7 receptors and methods of useIMMUNEX CORP·Filed 1990·Granted Mar 16, 1993·18 cites·16 claims
- 3861US7211259B14-1BB polypeptides and DNA encoding 4-1BB polypeptidesIMMUNEX CORP·Filed 1997·Granted May 1, 2007·9 cites·19 claims
- 3960US5359039AIsolated poxvirus A53R-equivalent tumor necrosis factor antagonistsIMMUNEX CORP·Filed 1993·Granted Oct 25, 1994·15 cites·2 claims
- 4060US2009270592A1Purified TNFR preparationsIMMUNEX CORP·Filed 2007·Application pending·0 cites
- 4156US5753203ACD30 ligand conjugatesIMMUNEX CORP·Filed 1995·Granted May 19, 1998·5 cites·16 claims
- 4256US2006110802A1Cytokine designated 4-1BB ligand and human receptor that binds theretoGOODWIN RAYMOND G·Filed 2003·Application pending·0 cites
- 4356US2009081700A1Methods of use of the TACI/TACI-L interactionIMMUNEX CORP·Filed 2008·Application pending·0 cites
- 4455US2005176640A1Viral proteins capable of binding LARIMMUNEX CORP·Filed 2004·Application pending·0 cites
- 4554US8133976B2Methods of use of the TACI/TACI-L interactionGOODWIN RAYMOND G·Filed 2009·Granted Mar 13, 2012·0 cites·1 claims
- 4654US2004180826A1Novel receptor that causes cell deathIMMUNEX CORP·Filed 2003·Application pending·0 cites
- 4752US2007298460A1Novel receptor that causes cell deathIMMUNEX CORP·Filed 2007·Application pending·0 cites
- 4849US2006127985A1Cytokine designated 4-1BB ligand and human receptor that binds theretoGOODWIN RAYMOND G·Filed 2005·Application pending·0 cites
- 4948US2008081043A1NK cell activation inducing ligand (NAIL) DNA and polypeptides, and use thereofKUBIN MAREK Z·Filed 2007·Application pending·0 cites
- 5042US2003165986A1Methods of use of the TACI/TACI-L interactionIMMUNEX CORP·Filed 2001·Application pending·0 cites
Showing the top 50 of 53 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Raymond G. Goodwin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →